Screening compound: InChI=1S/C25H22ClN3O2S/c26-19-10-8-18(9-11-19)25(31)12-14-28(15-13-25)24(30)22-17-21(23-7-4-16-32-23)27-29(22)20-5-2-1-3-6-20/h1-11,16-17,31H,12-15H2

Screening compound: InChI=1S/C25H22ClN3O2S/c26-19-10-8-18(9-11-19)25(31)12-14-28(15-13-25)24(30)22-17-21(23-7-4-16-32-23)27-29(22)20-5-2-1-3-6-20/h1-11,16-17,31H,12-15H2
Screening compound: InChI=1S/C25H22ClN3O2S/c26-19-10-8-18(9-11-19)25(31)12-14-28(15-13-25)24(30)22-17-21(23-7-4-16-32-23)27-29(22)20-5-2-1-3-6-20/h1-11,16-17,31H,12-15H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C25H22ClN3O2S/c26-19-10-8-18(9-11-19)25(31)12-14-28(15-13-25)24(30)22-17-21(23-7-4-16-32-23)27-29(22)20-5-2-1-3-6-20/h1-11,16-17,31H,12-15H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y041-0763

Molecular Formula

C25H22ClN3O2S (C25 H22 ClN3 O2 S)

Compound Name

4-(4-chlorophenyl)-1-[1-phenyl-3-(thiophen-2-yl)-1H-pyrazole-5-carbonyl]piperidin-4-ol

IUPAC name

4-(4-chlorophenyl)-1-[1-phenyl-3-(thiophen-2-yl)-1H-pyrazole-5-carbonyl]piperidin-4-ol

SMILES

OC(CC1)(CCN1C(c1cc(-c2cccs2)nn1-c1ccccc1)=O)c(cc1)ccc1Cl

InChI

InChI=1S/C25H22ClN3O2S/c26-19-10-8-18(9-11-19)25(31)12-14-28(15-13-25)24(30)22-17-21(23-7-4-16-32-23)27-29(22)20-5-2-1-3-6-20/h1-11,16-17,31H,12-15H2

InChI Key

KZMSPSPKVISERE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD18799769

InChI=1S/C25H22ClN3O2S/c26-19-10-8-18(9-11-19)25(31)12-14-28(15-13-25)24(30)22-17-21(23-7-4-16-32-23)27-29(22)20-5-2-1-3-6-20/h1-11,16-17,31H,12-15H2 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with InChI=1S/C25H22ClN3O2S/c26-19-10-8-18(9-11-19)25(31)12-14-28(15-13-25)24(30)22-17-21(23-7-4-16-32-23)27-29(22)20-5-2-1-3-6-20/h1-11,16-17,31H,12-15H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C25H22ClN3O2S/c26-19-10-8-18(9-11-19)25(31)12-14-28(15-13-25)24(30)22-17-21(23-7-4-16-32-23)27-29(22)20-5-2-1-3-6-20/h1-11,16-17,31H,12-15H2?
Check Price and Availability of InChI=1S/C25H22ClN3O2S/c26-19-10-8-18(9-11-19)25(31)12-14-28(15-13-25)24(30)22-17-21(23-7-4-16-32-23)27-29(22)20-5-2-1-3-6-20/h1-11,16-17,31H,12-15H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C25H22ClN3O2S/c26-19-10-8-18(9-11-19)25(31)12-14-28(15-13-25)24(30)22-17-21(23-7-4-16-32-23)27-29(22)20-5-2-1-3-6-20/h1-11,16-17,31H,12-15H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C25H22ClN3O2S/c26-19-10-8-18(9-11-19)25(31)12-14-28(15-13-25)24(30)22-17-21(23-7-4-16-32-23)27-29(22)20-5-2-1-3-6-20/h1-11,16-17,31H,12-15H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C25H22ClN3O2S/c26-19-10-8-18(9-11-19)25(31)12-14-28(15-13-25)24(30)22-17-21(23-7-4-16-32-23)27-29(22)20-5-2-1-3-6-20/h1-11,16-17,31H,12-15H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C25H22ClN3O2S/c26-19-10-8-18(9-11-19)25(31)12-14-28(15-13-25)24(30)22-17-21(23-7-4-16-32-23)27-29(22)20-5-2-1-3-6-20/h1-11,16-17,31H,12-15H2 available by request